http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103833731-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
filingDate 2011-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103833731-B
titleOfInvention The novel preparation method of chiral sulfoxide compounds and salt thereof and crystal formation
abstract The invention discloses novel preparation method and the crystal formation of chiral sulfoxide compounds and salt thereof, this preparation method is used for enantioselectivity preparation with single enantiomer form or to be rich in the chiral sulfoxides that enantiomeric form exists, in tartaric acid diamide ligands and titanium complexing, and under having water to exist, do not add the effect that alkali also can reach identical with during interpolation alkali, namely equal enantioselectivity and transformation efficiency.In addition, present invention also offers S-(-)-omeprazole sodium salt new crystal.
priorityDate 2011-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9579578
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29154
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23681230
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452464713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414671431
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419593355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452554216
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415832417
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID117410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505875
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559477
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453961775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584184
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID479
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69761375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23674541
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID192113
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152732532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20153849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448558341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457778434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415837858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25200171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419569664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29109

Total number of triples: 50.